MURPHY ANDREW J 1796226 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-10 | 2023-05-09 | 2023-05-09 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 1326.0 | 2.18 | 0.12 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code G | 59421.0 | 107.89 (REGN) |
| 2023-05-10 | 2023-05-09 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4304.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
| 2023-11-15 | 2023-11-13 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4310.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-11-15 | 2023-11-13 | 2023-11-13 to 2023-11-14 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 25.18 | 1.87 | 796.82 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F S | 59421.0
|
107.13 (REGN) |
| 2023-11-15 | 2023-11-13 | 2023-11-13 | 4 | Murphy Andrew J | EVP RESEARCH | acq | 20000.0 | 25.18 | 1.87 | 270.43 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 79421.0 | 107.13 (REGN) |
| 2023-12-06 | 2023-12-04 | 2023-12-04 to 2023-12-05 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 25.18 | 1.87 | 814.84 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F S | 59421.0
|
107.13 (REGN) |
| 2023-12-06 | 2023-12-04 | 2023-12-04 | 4 | Murphy Andrew J | EVP RESEARCH | acq | 20000.0 | 25.18 | 1.87 | 270.43 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 79421.0 | 107.13 (REGN) |
| 2023-12-06 | 2023-12-04 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4310.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Murphy Andrew J | EVP RESEARCH | acq | 3199.0 | 5.18 | 0.3 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 61737.0 | 107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 to 2023-12-11 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 6657.0 | 10.63 | 0.62 | 844.05 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 55963.0
|
107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4310.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-14 | 2023-12-12 | 2023-12-12 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 7657.0 | 13.68 | 0.71 | 856.71 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 48306.0 | 107.13 (REGN) |
| 2023-12-14 | 2023-12-12 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4310.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-03-15 | 2024-03-13 | 4 | Murphy Andrew J | EVP RESEARCH | holding | 4310.0 | 0 | 0.4 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-03-15 | 2024-03-13 | 2024-03-13 to 2024-03-14 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 29.28 | 1.85 | 967.38 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F S | 48306.0
|
107.94 (REGN) |
| 2024-03-15 | 2024-03-13 | 2024-03-13 | 4 | Murphy Andrew J | EVP RESEARCH | acq | 20000.0 | 29.28 | 1.85 | 399.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 68306.0 | 107.94 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-15 | 2023-11-13 | 2023-11-13 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 50.0 | 1.87 | 270.43 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 20000.0 | 107.13 (REGN) |
| 2023-12-06 | 2023-12-04 | 2023-12-04 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 100.0 | 1.87 | 270.43 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Murphy Andrew J | EVP RESEARCH | acq | 11473.0 | 100.0 | 1.07 | 843.79 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 11473.0 | 107.13 (REGN) |
| 2024-03-15 | 2024-03-13 | 2024-03-13 | 4 | Murphy Andrew J | EVP RESEARCH | dsp | 20000.0 | 50.0 | 1.85 | 399.66 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 20000.0 | 107.94 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)